We are live on
!
Find out more
Axa Portfolio holdings
AUM
$91.9M
1-Year Est. Return
27.41%
This Fund
S&P 500
This Quarter
Est. Return
+0.74%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$35.6B
AUM Growth
+$166M
(+0.47%)
Cap. Flow
+$350M
Cap. Flow
% of AUM
0.98%
Top 10 Holdings %
Top 10 Hldgs %
19.85%
Holding
1,363
New
118
Increased
473
Reduced
442
Closed
143
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AT&T
T
|
+$76.2M |
| 2 |
S&P Global
SPGI
|
+$73M |
| 3 |
Adobe
ADBE
|
+$62.1M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$56.5M |
| 5 |
NVIDIA
NVDA
|
+$52.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BNY
Bank of New York Mellon
BNY
|
+$60.1M |
| 2 |
Colgate-Palmolive
CL
|
+$57.1M |
| 3 |
Cisco
CSCO
|
+$55.2M |
| 4 |
Generac Holdings
GNRC
|
+$44.8M |
| 5 |
Alibaba
BABA
|
+$42.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.95% |
| 2 | Healthcare | 17.81% |
| 3 | Consumer Discretionary | 11.77% |
| 4 | Financials | 10.45% |
| 5 | Industrials | 7.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Idexx Laboratories
IDXX
$40.1B
| $81.2M | 0.23% |
130,582
+70,619
| +118% | +$47.5M |
|
102
Eli Lilly
LLY
$1.01T
| $80.6M | 0.23% |
348,678
-10,658
| -3% | -$2.63M |
|
103
Comcast
CMCSA
$88.3B
| $80.2M | 0.23% |
1,434,562
-32,207
| -2% | -$1.88M |
|
104
Cognex
CGNX
$10.8B
| $80.1M | 0.22% |
998,604
-42,243
| -4% | -$3.64M |
|
105
Starbucks
SBUX
$113B
| $80.1M | 0.22% |
726,063
+29,323
| +4% | +$3.43M |
|
106
Illumina
ILMN
$31.4B
| $79.6M | 0.22% |
201,802
-2,336
| -1% | -$1.07M |
|
107
HDFC Bank
HDB
$118B
| $78.9M | 0.22% |
2,158,140
+116,276
| +6% | +$4.31M |
|
108
Walt Disney
DIS
$188B
| $78.8M | 0.22% |
465,835
-695
| -0.1% | -$124K |
|
|
FISV
109
Fiserv Inc
FISV
$27.1B
| $78.7M | 0.22% |
725,548
+95,204
| +15% | +$10.6M |
|
|
ZEN
110
DELISTED
ZENDESK INC
ZEN
| $78.1M | 0.22% |
671,319
+100,944
| +18% | +$13M |
|
111
Applied Materials
AMAT
$337B
| $78.1M | 0.22% |
606,841
-15,853
| -3% | -$2.15M |
|
112
General Motors
GM
$76.5B
| $77.7M | 0.22% |
1,474,790
+97,130
| +7% | +$5.16M |
|
|
113
Bristol-Myers Squibb
BMY
$131B
| $76.7M | 0.22% |
1,295,663
+857,271
| +196% | +$56.5M |
|
114
Vertex Pharmaceuticals
VRTX
$132B
| $76.5M | 0.21% |
421,889
+198,955
| +89% | +$38.8M |
|
115
Veeva Systems
VEEV
$43B
| $76.4M | 0.21% |
264,996
+40,670
| +18% | +$12.9M |
|
116
Boston Scientific
BSX
$65.3B
| $76.3M | 0.21% |
1,757,866
+242,976
| +16% | +$10.7M |
|
117
Cummins
CMI
$74.5B
| $76M | 0.21% |
338,465
+161,610
| +91% | +$37.9M |
|
118
Ambarella
AMBA
$2.82B
| $74.8M | 0.21% |
480,061
-21,462
| -4% | -$2.47M |
|
|
ANSS
119
DELISTED
Ansys
ANSS
| $73.7M | 0.21% |
216,465
-9,685
| -4% | -$3.5M |
|
|
ABMD
120
DELISTED
Abiomed Inc
ABMD
| $73.5M | 0.21% |
225,686
-10,538
| -4% | -$3.57M |
|
121
Stryker
SYK
$108B
| $73.4M | 0.21% |
278,259
+4,506
| +2% | +$1.2M |
|
122
HP
HPQ
$30.7B
| $73.2M | 0.21% |
2,675,643
+563,098
| +27% | +$16.2M |
|
123
IPG Photonics
IPGP
$3.4B
| $73M | 0.2% |
460,840
-19,671
| -4% | -$3.61M |
|
124
Bank of America
BAC
$416B
| $72.9M | 0.2% |
1,718,225
-142,312
| -8% | -$5.73M |
|
125
Emerson Electric
EMR
$84.9B
| $72.9M | 0.2% |
773,716
-260,040
| -25% | -$25.9M |
|
Similar funds
VI
FA
PBCM
CCAM
GBA
AWP
HI
DCA
Axa's Q3 2021 Portfolio in Review
As of Q3 2021, Axa held 1,363 positions worth $35.6B, up 0.47% from $35.5B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Axa's Q3 2021 filing shows 118 new, 473 increased, 442 reduced and 143 closed positions. Its largest new stake was GXO Logistics: 575,960 shares worth $45.2M. The largest sale was Bank of New York Mellon, an estimated $60.1M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 30% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Axa's largest Q3 2021 buy was GXO Logistics: 575,960 shares worth $45.2M.
- Axa added most to AT&T in Q3 2021, an estimated $76.2M increase.
- Axa's biggest Q3 2021 reduction was Bank of New York Mellon, cutting an estimated $60.1M.
- Axa fully exited Proofpoint, Inc. in Q3 2021, selling an estimated $35.3M.
- Axa's ten largest holdings make up 20% of its $35.6B portfolio in Q3 2021.
- Axa opened 118 new positions and closed 143 in Q3 2021.
- Axa's portfolio value rose 0.47% quarter-over-quarter to $35.6B.
Based on Axa's 13F filing for Q3 2021, filed 15 Nov 2021.